Literature DB >> 18291368

Epigenetic silencing of maspin expression occurs early in the conversion of keratocytes to fibroblasts.

Mark A Horswill1, Malathi Narayan, Debra J Warejcka, Lisa A Cirillo, Sally S Twining.   

Abstract

Maspin, a 42 kDa non-classical serpin (serine protease inhibitor) that controls cell migration and invasion, is mainly expressed by epithelial-derived cells but is also expressed in corneal stromal keratocytes. Upon culture of stromal keratocytes in the presence of FBS, maspin is down-regulated to nearly undetectable levels by passage two. DNA methylation is one of several processes that controls gene expression during cell differentiation, development, genetic imprinting, and carcinogenesis but has not been studied in corneal stromal cells. The purpose of this study was to determine whether DNA methylation of the maspin promoter and histone H3 dimethylation is involved in the mechanism of down-regulation of maspin synthesis in human corneal stromal fibroblasts and myofibroblasts. Human donor corneal stroma cells were immediately placed into serum-free defined medium or cultured in the presence of FBS and passed into serum-free medium or medium containing FBS or FGF-2 to induce the fibroblast phenotype or TGF-beta1 for the myofibroblast phenotype. These cell types are found in wounded corneas. The cells were used to prepare RNA for semi-quantitative or quantitative RT-PCR or to extract protein for Western analysis. In addition, P4 FBS cultured fibroblasts were treated with the DNA demethylating agent, 5-aza-2'-deoxycytidine (5-Aza-dC), and the histone deacetylase inhibitor, trichostatin A (TSA). Cells with and without treatment were harvested and assayed for DNA methylation using sodium bisulfite sequencing. The methylation state of histone H3 associated with the maspin gene in the P4 fibroblast cells was determined using a ChIP assay. Freshly harvested corneal stromal cells expressed maspin but upon phenotypic differentiation, maspin mRNA and protein were dramatically down-regulated. Sodium bisulfite sequencing revealed that the maspin promoter in the freshly isolated stromal keratocytes was hypomethylated while both the P0 stromal cells and the P1 cells cultured in the presence of serum-free defined medium, FGF-2 and TGF-beta1 were hypermethylated. Down-regulation of maspin synthesis was also associated with histone H3 dimethylation at lysine 9. Both maspin mRNA and protein were re-expressed at low levels with 5-Aza-dC but not TSA treatment. Addition of TSA to 5-Aza-dC treated cells did not increase maspin expression. Treatment with 5-Aza-dC did not significantly alter demethylation of the maspin promoter but did demethylate histone H3. These results show maspin promoter hypermethylation and histone methylation occur with down-regulation of maspin synthesis in corneal stromal cells and suggest regulation of genes upon conversion of keratocytes to wound healing fibroblasts can involve promoter and histone methylation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18291368      PMCID: PMC2374753          DOI: 10.1016/j.exer.2008.01.003

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  68 in total

Review 1.  Epigenetic gene silencing in cancer.

Authors:  B Tycko
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

Review 2.  X inactivation, differentiation, and DNA methylation.

Authors:  A D Riggs
Journal:  Cytogenet Cell Genet       Date:  1975

3.  Aberrant methylation of the maspin promoter is an early event in human breast cancer.

Authors:  Bernard W Futscher; Megan M O'Meara; Christina J Kim; Margaret A Rennels; Di Lu; Lynn M Gruman; Richard E B Seftor; Mary J C Hendrix; Frederick E Domann
Journal:  Neoplasia       Date:  2004 Jul-Aug       Impact factor: 5.715

4.  DNA modification mechanisms and gene activity during development.

Authors:  R Holliday; J E Pugh
Journal:  Science       Date:  1975-01-24       Impact factor: 47.728

5.  Epigenetic silencing of maspin gene expression in human breast cancers.

Authors:  F E Domann; J C Rice; M J Hendrix; B W Futscher
Journal:  Int J Cancer       Date:  2000-03-15       Impact factor: 7.396

6.  5-Aza-2'-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumor suppressor gene reactivation.

Authors:  R J Wozniak; W T Klimecki; S S Lau; Y Feinstein; B W Futscher
Journal:  Oncogene       Date:  2006-06-26       Impact factor: 9.867

7.  Re-activation of a dormant tumor suppressor gene maspin by designed transcription factors.

Authors:  A Beltran; S Parikh; Y Liu; B D Cuevas; G L Johnson; B W Futscher; P Blancafort
Journal:  Oncogene       Date:  2006-10-23       Impact factor: 9.867

8.  Epigenetic silencing through DNA and histone methylation of fibroblast growth factor receptor 2 in neoplastic pituitary cells.

Authors:  Xuegong Zhu; Katie Lee; Sylvia L Asa; Shereen Ezzat
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

9.  Maspin expression in normal lung and non-small-cell lung cancers: cellular property-associated expression under the control of promoter DNA methylation.

Authors:  Yasushi Yatabe; Tetsuya Mitsudomi; Takashi Takahashi
Journal:  Oncogene       Date:  2004-05-20       Impact factor: 9.867

10.  Ikaros is regulated through multiple histone modifications and deoxyribonucleic acid methylation in the pituitary.

Authors:  Xuegong Zhu; Sylvia L Asa; Shereen Ezzat
Journal:  Mol Endocrinol       Date:  2007-03-06
View more
  12 in total

1.  Maspin increases extracellular plasminogen activator activity associated with corneal fibroblasts and myofibroblasts.

Authors:  Debra J Warejcka; Malathi Narayan; Sally S Twining
Journal:  Exp Eye Res       Date:  2011-07-27       Impact factor: 3.467

2.  Genomic DNA hypomethylation by histone deacetylase inhibition implicates DNMT1 nuclear dynamics.

Authors:  Mohsen Karimi Arzenani; Atosa Esteki Zade; Yu Ming; Susanne J H Vijverberg; Zhe Zhang; Zahidul Khan; Syed Sadique; Lorenz Kallenbach; LiFu Hu; Vladana Vukojević; Tomas J Ekström
Journal:  Mol Cell Biol       Date:  2011-07-26       Impact factor: 4.272

3.  Deletion of neural tube defect-associated gene Mthfd1l causes reduced cranial mesenchyme density.

Authors:  Minhye Shin; Amanda Vaughn; Jessica Momb; Dean R Appling
Journal:  Birth Defects Res       Date:  2019-09-13       Impact factor: 2.344

4.  Folate-dependent methylation of septins governs ciliogenesis during neural tube closure.

Authors:  Manami Toriyama; Michinori Toriyama; John B Wallingford; Richard H Finnell
Journal:  FASEB J       Date:  2017-04-21       Impact factor: 5.191

5.  Mitochondrial C1-tetrahydrofolate synthase (MTHFD1L) supports the flow of mitochondrial one-carbon units into the methyl cycle in embryos.

Authors:  Schuyler T Pike; Rashmi Rajendra; Karen Artzt; Dean R Appling
Journal:  J Biol Chem       Date:  2009-11-30       Impact factor: 5.157

6.  Focus on molecules: maspin.

Authors:  Malathi Narayan; Sally Twining
Journal:  Exp Eye Res       Date:  2009-07-15       Impact factor: 3.467

7.  Epigenetic reprogramming during wound healing: loss of polycomb-mediated silencing may enable upregulation of repair genes.

Authors:  Tanya Shaw; Paul Martin
Journal:  EMBO Rep       Date:  2009-07-03       Impact factor: 8.807

8.  Deletion of Mthfd1l causes embryonic lethality and neural tube and craniofacial defects in mice.

Authors:  Jessica Momb; Jordan P Lewandowski; Joshua D Bryant; Rebecca Fitch; Deborah R Surman; Steven A Vokes; Dean R Appling
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-24       Impact factor: 11.205

9.  Human Chondrosarcoma Cells Acquire an Epithelial-Like Gene Expression Pattern via an Epigenetic Switch: Evidence for Mesenchymal-Epithelial Transition during Sarcomagenesis.

Authors:  Matthew P Fitzgerald; Francoise Gourronc; Melissa L T Teoh; Matthew J Provenzano; Adam J Case; James A Martin; Frederick E Domann
Journal:  Sarcoma       Date:  2011-03-17

10.  Histone deacetylase inhibitors blocked activation and caused senescence of corneal stromal cells.

Authors:  Qingjun Zhou; Yao Wang; Lingling Yang; Ye Wang; Peng Chen; Yiqiang Wang; Xiaoguang Dong; Lixin Xie
Journal:  Mol Vis       Date:  2008-12-30       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.